Life Science Connect

Four biopharma CEOs discuss with Rob Wright, chief editor of Life Science Leader, how they are leading their organizations and conducting drug development during the COVID-19 pandemic.

Three CEOs of publicly traded biopharmaceutical companies discuss how they are leading their organizations, while also managing the expectations of Wall St. during the COVID-19 pandemic.

Five biopharmaceutical industry CEOs discuss challenges their companies have faced, along with best practices implemented in managing through the COVID-19 chaos.

Starting in April 2021, each week we will be releasing the audio portion of various episodes of our popular Executive Virtual Roundtables (EVRs). In them, we cover topics such as leadership and drug development during COVID, how to accelerate a biopharma path to the clinic, virtual pitching and fundraising, and diversity and inclusion in pharma. You can watch all of our Executive Virtual Roundtable videos here.

BioProcess Online Chief Editor, Matt Pillar, discusses the current vaccine market, some advancements that have been made, and if its growth is sustainable. 

Will decentralized clinical trials continue to be a hot topic even after the pandemic or will pharma companies revert to their old ways. Our guest, ClinicalLeader.com Chief Editor, Ed Miseta, weighs in on this timely topic.

Life Science Leader Chief Editor Rob Wright has attended numerous JPM conferences, so he gives his feedback on how this year’s virtual show compared to previous years.

Erin Harris, Chief Editor of cellandgene.com, reviews some of the hot cell and gene therapy topics for 2020 and what to watch for in 2021. She also discusses the upcoming Cell & Gene Live! event and the miniseries she did for the Business of Biotech podcast. 

2020 seems to be the year of the evolution of the atypical, newfangled CDMO. Outsourced Pharma Chief Editor Louis Garguilo talks about this trend and what makes these new models all the rage.

Today’s guest, Matt Pillar, not only hosts two of his own podcasts, but is our Chief Editor for BioProcess Online. Matt gives a peek into what trends he wrote about for the Life Science Leader outlook issue, and he talks about what’s next for his Business of Biotech podcast.